Patent details

EP3054948 Title: RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

Basic Information

Publication number:
EP3054948
PCT Application Number:
US2014059529
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148516438
PCT Publication Number:
WO2015054280
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS
French Title of Invention:
RAPAMYCINE POUR LE TRAITEMENT DE LA LYMPHANGIOLÉIOMYOMATOSE
German Title of Invention:
RAPAMYCIN ZUR BEHANDLUNG VON LYMPHANGIOLEIOMYOMATOSE
SPC Number:

Dates

Filing date:
07/10/2014
Grant date:
12/08/2020
EP Publication Date:
17/08/2016
PCT Publication Date:
16/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/08/2020
EP B1 Publication Date:
12/08/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/10/2020
Expiration date:
07/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/08/2020
 
 

Name:
AI Therapeutics, Inc.
Address:
530 Old Whitfield Street, Guilford CT 06437, United States (US)

Inventor

1

Name:
ROTHBERG, Jonathan M.
Address:
United States (US)

2

Name:
ARMER, Thomas
Address:
United States (US)

3

Name:
LICHENSTEIN, Henri
Address:
United States (US)

4

Name:
MELVIN, Jr Lawrence S.
Address:
United States (US)

Priority

Priority Number:
201361888066 P
Priority Date:
08/10/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/14; A61K 9/16; A61K 31/436; A61K 47/26;

Publication

European Patent Bulletin

Issue number:
202033
Publication date:
12/08/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages